DrugPatentWatch Database Preview
Sandoz Inc Company Profile
What is the competitive landscape for SANDOZ INC, and what generic alternatives to SANDOZ INC drugs are available?
There are two US patents protecting SANDOZ INC drugs. There are fifteen tentative approvals on SANDOZ INC drugs.
There are twenty patent family members on SANDOZ INC drugs in eighteen countries and one hundred and seventy-seven supplementary protection certificates in twelve countries.
Summary for Sandoz Inc
| International Patents: | 20 |
| US Patents: | 2 |
| Tradenames: | 108 |
| Ingredients: | 104 |
| NDAs: | 136 |
Drugs and US Patents for Sandoz Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz Inc | DOXERCALCIFEROL | doxercalciferol | INJECTABLE;INJECTION | 091333-001 | May 5, 2014 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sandoz Inc | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 201692-003 | May 31, 2012 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sandoz Inc | ARISTOSPAN | triamcinolone hexacetonide | INJECTABLE;INJECTION | 016466-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Sandoz Inc | DOXYCYCLINE | doxycycline | TABLET;ORAL | 065353-001 | Nov 27, 2006 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Sandoz Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,342,783 | ➤ Sign Up |
| Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,252,984 | ➤ Sign Up |
| Sandoz Inc | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | 4,311,708 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Sandoz Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,261,547 | Gelling ophthalmic compositions containing xanthan gum | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Sandoz Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 9951273 | ➤ Sign Up |
| Germany | 69909768 | ➤ Sign Up |
| New Zealand | 506921 | ➤ Sign Up |
| Brazil | 9910113 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Sandoz Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0030 | France | ➤ Sign Up | PRODUCT NAME: VORICONAZOLE; NAT. REGISTRATION NO/DATE: EU/1/02/212/001-025 20020319; FIRST REGISTRATION: EU/1/02/212/001-25 20020319 |
| C/GB96/058 | United Kingdom | ➤ Sign Up | PRODUCT NAME: OLANZAPINE OPTIONALLY IN THE FORM OF AN ACID ADDITION SALT; REGISTERED: UK EU/1/96/022/001 19960927; UK EU/1/96/022/002 19960927; UK EU/1/96/022/003 19960927; UK EU/1/96/022/004 19960927; UK EU/1/96/022/005 19960927; UK EU/1/96/022/006 19960927; UK EU/1/96/022/007 19960927; UK EU/1/96/022/008 19960927; UK EU/1/96/022/009 19960927; UK EU/1/96/022/010 19960927 |
| C0046 | Belgium | ➤ Sign Up | PRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624 |
| 0244 | Netherlands | ➤ Sign Up | PRODUCT: TIGECYCLINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF METAALCOMPLEX, IN HET BIJZONDER TIGECYCLINE; FIRST REGISTRATION, DATE: EU/1/06/336/001, 20060424 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
